Carbon inhibits vascular endothelial growth factor‐ and fibroblast growth factor‐promoted angiogenesis
Open Access
- 20 February 2007
- journal article
- research article
- Published by Wiley in FEBS Letters
- Vol. 581 (6) , 1157-1160
- https://doi.org/10.1016/j.febslet.2007.02.022
Abstract
Angiogenesis is important for normal growth and wound healing processes. An imbalance of the growth factors involved in this process, however, causes the acceleration of several diseases including ma...Keywords
This publication has 16 references indexed in Scilit:
- Blood Compatible Carbon Nanotubes − Nano-based NeoproteoglycansLangmuir, 2006
- Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracersProceedings of the National Academy of Sciences, 2006
- Nano-oncology: drug delivery, imaging, and sensingAnalytical and Bioanalytical Chemistry, 2006
- Angiogenesis in life, disease and medicineNature, 2005
- Angiogenic inhibitors: a new therapeutic strategy in oncologyNature Clinical Practice Oncology, 2005
- Angiogenesis inhibitors in the treatment of cancerExpert Opinion on Pharmacotherapy, 2005
- Applications of Carbon Nanotubes in Biotechnology and BiomedicineJournal of Biomedical Nanotechnology, 2005
- A Review of Nanotechnology for the Development of Better Orthopedic ImplantsJournal of Biomedical Nanotechnology, 2005
- Gold Nanoparticles Inhibit VEGF165-Induced Proliferation of HUVEC CellsNano Letters, 2004
- Proangiogenic Action of Thyroid Hormone Is Fibroblast Growth Factor–Dependent and Is Initiated at the Cell SurfaceCirculation Research, 2004